This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Indian medical devices companies are increasingly looking to invest in innovation for developing products that help to minimize environmental footprint.
The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new era of genomic medicine for the NHS. The post New era of genomic medicine begins as UK approves Lilly’s Retsevmo appeared first on.
This reach allows us to support 82% of the novel drugs and therapeutic products approved by the US FDA, including 63% of those specific to oncology,” Reddy states. The test informs HCPs through a comprehensive genomic and immune profiling test clinically and analytically validated for all solid tumours. Navigating barriers to access.
Genetic engineering has the potential to transform how we raise animals for meat and other products, making food safer, improving animal health and welfare, and shrinking animal agriculture’s environmental footprint. Pigs that are less likely to induce allergic reactions in humans. Read the rest…
In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?
A global effort to map the genomes of all plants, animals, fungi and other microbial life on Earth, is entering a new phase as it moves from pilot projects to full-scale production sequencing. This new phase of the The Earth BioGenome Project, or EBP, is marked with a collection of papers published this week (Jan. […].
A study led by scientists at the Universitat Autònoma de Barcelona (UAB) and University of Kent uncovers how the genome three-dimensional structure of male germ cells determines how genomes evolve over time.
Credit: Photo: IPK Leibniz Institute/ Andreas Bähring In order to record all genetic information of an individual, its genome must be completely decoded. IPK scientists and international partners for barley already succeeded in doing this three years ago (Mascher et al.
Research team from the Universities of Göttingen and British Columbia investigates evaluations of breeding technology A research team from the University of Göttingen and the University of British Columbia (Canada) has investigated how people in five different countries react to various usages of genome editing in agriculture.
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.
Sangamo Therapeutics has received orphan medicinal product designation (OMPD) from the European Commission (EC) for its Investigational autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy, TX200, for solid organ transplantation.
BIO, the worldâs largest trade association for the biotech industry, has responded to the US Food and Drug Administration's draft guidance on developing human gene therapy products that incorporate genome editing (GE) of human somatic cells.
firm best known for its niche approach to DNA sequencing, on Tuesday announced plans to launch a new product that will put the company in direct competition with genomics juggernaut Illumina. The new DNA sequencer, dubbed Onso, reads the genome in small pieces and uses software to stitch that information together.
Credit: Montgomery Flack URBANA, Ill. – Pumpkin growers dread the tiny tan scabs that form on their fruit, each lesion a telltale sign of bacterial spot disease.
Act now to ensure animal welfare is at the heart of plans to introduce genome editing into farmed animal breeding, says independent ethics body The Nuffield Council on Bioethics is calling on the Government to put animal welfare at the heart of plans to approve new breeding technologies in farming and food production, in a […].
2021 Agricultural Greater Good Grant awarded to Göttingen University molecular biologist The international Illumina Agricultural Greater Good Grant recognizes research proposals that will increase the sustainability, productivity, and nutritional density of agriculturally important crop and livestock species.
Lee Honigberg on the Future of Blood-Based Biomarker Assays GeneDX GeneDX recently integrated AI (Multiscore) into its interpretation platform, improving speed and accuracy in analyzing complex genomic data. 10x Genomics 10x Genomics reported $707 million in 2024 revenue.
First, a novel approach was used that didn’t require traditional vaccine production in cell cultures or eggs. Both the Pfizer and Moderna vaccines copied RNA sequence from the virus genome and found a way to manufacture it at scale with high-level processes and quality control. 1455NO-HEALTH-CORONAVIRUS_VACCINES_PFIZER_O_.
(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.
Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s status as a major pharma production and export hub. In turn, the solution provider contributes to a reliable cool chain for highly sensitive pharmaceutical products, especially during the pandemic.
The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to read genetic information accurately and cheaply. Continue to STAT+ to read the full story…
Vivlion holds an exclusive license to Goethe University of Frankfurt’s proprietary 3Cs technology for the production of next generation 3Cs CRISPR/Cas gRNA libraries. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. “The 1, 2020 09:04 UTC.
Genome Editing in Plants The FDA has also released guidance for foods derived from plants produced using genome editing. This guidance aims to address the regulatory framework and safety assessments for genome-edited plant foods, providing clarity for industry participants involved in developing these innovative products.
Sun Genomics Expands Testing Options for its Floré Gut Health Suite of Products Sun Genomics Expands Testing Options for its Floré Gut Health Suite of Products The Customized Probiotic Company’s Founder and CEO Will Discuss the New Offerings, In Addition … Continue reading →
The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products. Its focus areas include human systems, precision diagnostics, data sciences, next-generation biomanufacturing, and genomic medicines. The University of Pennsylvania Immunotherapy Richard W.
COVID: AHF Lauds Biden’s Use of Defense Production Act, Urges Boost to Genomic Sequencing COVID: AHF Lauds Biden’s Use of Defense Production Act, Urges Boost to Genomic Sequencing LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), the world’s largest AIDS organization, applauds … Continue reading →
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. Cancer is a disease of the genome and treatment no longer depends solely on the tissue of origin.
EchelonDx and Cradle Genomics Join Forces to Accelerate Development of Comprehensive Non-Invasive Prenatal Diagnostic Products EchelonDx and Cradle Genomics Join Forces to Accelerate Development of Comprehensive Non-Invasive Prenatal Diagnostic Products Complementary technologies will transform data analysis and reporting capabilities for … Continue (..)
Department of Energy (DOE) announced a plan to provide up to $30 million for basic research that will lead to transformative approaches to determine and validate gene function in plant species relevant to the sustainable production of bioenergy and bioproducts.
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening — Population Genetics Sequencing Panel Incorporates … Continue reading (..)
The gene-editing technology allows for precise, directed changes to genomic DNA. The company will also be eligible to receive research and development milestones of up to an additional $230m, along with royalties on any future products resulting from the deal. The system comprises the Cas9 enzyme and a guide RNA.
LifeMine has developed an industrialised, genomics-based discovery engine that it hopes will take a broad, systematic approach to identifying new compounds from fungi and screening them for activity against disease targets. Image by jggrz from Pixabay . The post GSK partners LifeMine on fungi-derived medicines appeared first on.
Global Genome Sequencing Industry Worth $24.37 Billion by 2030 – Annual Revenue Breakdowns by Product, Technology, Application, End-user and Region – ResearchAndMarkets.com Global Genome Sequencing Industry Worth $24.37
Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit Baxter to Present at UBS Genomics 2.0 NYSE:BAX), a leading global medical products company, will present at the UBS Genomics … Continue reading → and MedTech Innovations Summit DEERFIELD, Ill.–(BUSINESS
The alliance will leverage the CRISPR genome editing technologies of Scribe to facilitate in genetic modification of new natural killer (NK) cell therapeutics for cancer. Sanofi will also make tiered royalty payments on net sales of products resulting from the collaboration in the future.
Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. In October, the U.S.
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product … Continue reading →
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content